Serum IgA, IgG, and IgM antibodies directed against acetaldehyde- derived epitopes: Relationship to liver disease severity and alcohol consumption

Hepatology

Volumn 25, Issue 6, 1997, Pages 1418-1424

  Vhtala, Katja ^a   Israel, Yedy ^b,c   Blake, Joan E ^b,c   Niemelä, Onni ^a,d  

^a EP Central Hospital Laboratory   (Finland)

^b UNIVERSITY OF OULU   (Finland)

^c CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^d EP Central Hospital Laboratory   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETALDEHYDE; ALCOHOL; BILIRUBIN; EPITOPE; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN CLASS; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 6;

ALCOHOL CONSUMPTION; ALCOHOL LIVER DISEASE; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; DISEASE SEVERITY; DNA ADDUCT; FEMALE; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ACETALDEHYDE; ALCOHOL DRINKING; ANTIBODIES; DISEASE PROGRESSION; EPITOPES; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LIVER DISEASES; MALE; REFERENCE VALUES;

EID: 20644453966     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510250619     Document Type: Article

References (19)

1. Lieber CS. Metabolic effects of acetaldehyde. Biochem Soc Transact 1988;16:241-247.
2. Israel Y, Hurwitz E, Niemelä O, Arnon R. Monoclonal and polyclonal antibodies against acetaldehyde-containing epitopes in acetaldehyde-protein adducts. Proc Natl Acad Sci U S A 1986;83:7923-7927.
3. Niemelä O, Klajner F, Orrego H, Vidins E, Blendis L, Israel Y. Antibodies against acetaldehyde-modified protein epitopes in human alcoholics. HEPATOLOGY 1987;7:1210-1214.
4. Hoerner M, Behrens UJ, Werner TM, Blacksberg I, Braley R, Schaffner F, Lieber CS. The role of alcoholism and liver disease in the appearance of serum antibodies against acetaldehyde adducts. HEPATOLOGY 1988;8:569-574.
5. Izumi N, Sakai Y, Koyama W, Hasumura Y. Clinical significance of serum antibodies against alcohol-altered hepatocyte membrane in alcoholic liver disease. Alcohol Clin Exp Res 1989;13:762-765.
6. Worrall S, de Jersey J, Shanley BC, Wilce PA. Antibodies against acetaldehyde-modified epitopes: an elevated IgA response in alcoholics. Eur J Clin Invest 1991;21:90-95.
7. Koskinas J, Kenna JG, Bird GL, Alexander GJM, Williams R. Immunoglobulin A antibody to a 200-kilodalton cytosolic acetaldehyde adduct in alcoholic hepatitis. Gastroenterology 1992;103:1860-1867.
8. Orrego H, Israel Y, Blake JE, Medline A. Assessment of prognostic factors in alcoholic liver disease: toward a global quantitative expression of severity. HEPATOLOGY 1983;3:896-905.
9. Blake J, Orrego H. Monitoring treatment of alcoholic liver disease: evaluation of various severity indices. Clin Chem 1991;37:5-13.
10. Orrego H, Blake JE, Blendis LM, Medline A. Prognosis of alcoholic cirrhosis in the presence and absence of alcoholic hepatitis. Gastroenterology 1987;92:208-214.
11. Niemelä O, Risteli J, Blake JE, Risteli L, Compton KV, Orrego H. Markers of fibrogenesis and basement membrane formation in alcoholic liver disease. Relation to severity, presence of hepatitis, and alcohol intake. Gastroenterology 1990;98:1612-1619.
12. Moncada C, Torres V, Varghese G, Albano E, Israel Y. Ethanol-derived immunoreactive species formed by free radical mechanisms. Mol Pharmacol 1994;46:786-791.
13. Niemelä O. Radioimmunoassays for type III procollagen peptides in humans. Clin Chem 1985;31:1301-1304.
14. Lin RC, Shahidi S, Lumeng L. Production of antibodies that recognize the heterogeneity of immunoreactive sites in human hemoglobin chemically modified by acetaldehyde. Alcohol Clin Exp Res 1993;17:882-886.
15. Tuma DJ, Newman MR, Donohue TM, Sorrell MF. Covalent binding of acetaldehyde to proteins: participation of lysine residues. Alcohol Clin Exp Res 1987;11:579-584.
16. Mauch TJ, Donohue TM, Zettermann RK, Sorrell MF, Tuma DJ. Covalent binding of acetaldehyde selectively inhibits the catalytic activity of lysine-dependent enzymes. HEPATOLOGY 1986;6:263-269.
17. San George RC, Hoberman HD. Reaction of acetaldehyde with hemoglobin. J Biol Chem 1986;261:6811-6821.
18. Fowles LF, Beck E, Worrall S, Shanley BC, de Jersey J. The formation and stability of imidazolidinone adducts from acetaldehyde and model peptides. A kinetic study with implications for protein modification in alcohol abuse. Biochem Pharmacol 1996;51:1259-1267.
19. Yokoyama H, Nagata S, Moriya S, Kato S. Circulating antibody to the protein epitope modified with high concentration of acetaldehyde (HA epitope) in alcoholics [Abstract]. Gastroenterology 1995;108:A1204.